Acadia Pharmaceuticals | ACAD - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
ALKERMES USD 456.48M 48.85M 2026-06
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Cara Therapeutics USD 2.24M 2.26M 2025-03
Corcept Therapeutics USD 76.92M 37.85M 2026-06
Cytokinetics USD 6.83M 10.94M 2026-03
Eisai JPY 253.13B 26.12B 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
Incyte USD 1.13B 73.7M 2026-06
J&J USD 22.54B 1.21B 2026-03
Moderna USD 17M 54M 2026-06
Neurocrine Biosciences USD 887M 118.9M 2026-06
Pfizer USD 16.19B 19M 2026-06
Prothena USD 5.16M 0 2023-12
PTC Therapeutics USD 219.92M 38.3M 2026-03
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06